By rray, 22 February, 2024 Treatments w no or uncertain benefits oral steroids C antitussives C vasodilators B drugs for primary pulm HTN B mepolizumab benralizumab dupilumab nedocromil leukotriene modifiers infliximab immunostimulants beta blockers if no CV indication for use simv
By rray, 22 February, 2024 Follow COVID 19 mitigation strategies and test for SARS CoV 2 if warranted e g new or worsening resp sx fever loss of taste and or smell If SARS CoV 2 pos continue usual COPD meds
By rray, 22 February, 2024 Consider shielding measures e g masking social distancing handwashing to prevent exac in winter months
By rray, 22 February, 2024 Evaluate and treat comorbidities CVD skeletal muscle dysfxn metabolic syndrome osteoporosis depression anxiety lung CA
By rray, 22 February, 2024 Create written COPD exac action plan w educational component maintain regular clinician contact
By rray, 22 February, 2024 If environment risks efficient ventilation nonpolluting cooking stoves etc B avoidance of irritants if possible D